跳至主要内容
临床试验/CTRI/2024/11/076677
CTRI/2024/11/076677尚未招募4 期

A Randomised Controlled Trial To Evaluate The Efficacy Of Kampilladi Churna In The Management Of Madhumeha W.S.R. To Diabetes Mellitus Type II.

Dr Bhumika Rajai1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2024年11月22日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
1.To evaluate the clinical efficacy of Kampilladi churna in the management of

研究概览

简要总结

Ayurvedic remedies for Madhumeha(Diabetes mellitus) are the oldest among all the available therapies, which includes in the prameha category. Pramehas are a list of urinary disorders, especially characterized by profuse urination with several abnormal qualities due to doshik imbalancesP rameha has been mentioned that it is a group of disorders in which there is an increased frequency of micturition, the volume of urine is also increased, and the urine becomes turbid. Acharyas have explained that in Madhumeha there is vitiation of Vata Kapha Pradhana Tridosha associated with Meda and other Dhatus along with Ojas as Dushya which comes out of the body through Mutravaha Srotas.

A similar disease has been described in modern medical sciences as Diabetes Mellitus type 2 .Ramchandran A (2012)Diabetes Mellitus (DM) refers to a group of metabolic disorders characterized by chronic hyperglycaemia, polyuria, polydipsia, polyphagia, emaciation, and weakness due to disturbance in carbohydrate, fat and protein metabolism associated with a relative or absolute deficiency in insulin secretion, insulin action or both

Diabetes mellitus is defined as a disturbance of intermediary metabolism manifesting as chronic sustained hyperglycemia primarily due to either an absolute or relative lack of insulin. W.H.O Consultation (2014)has classified Diabetes mellitus in Four types .Although the prevalences of Type 2 Diabetes mellitus is increasing worldwide than Type 1, Prevalence rate of Diabetes Mellitus In India is 11.3% with (95% type II DM)

Rationale of Study

Rationale of study

Now a days due to sedentary lifestyle, junk food consumption and lack of exercise, all this factor hampers metabolism and as a result people are suffering from Diabetes and young generation are at risk of getting Diabetes.The most important thing is ,oral hypoglycemic agents have side effects like sudden hypoglycemia, gastro intestinal tract upset etc Moreover these drugs corrects only hyperglycemia and not the basic pathology ,these drugs prevent further progress of disease and in spite ,patients lands into life threatening complications and therefore there is need of safe and natural remedy.

Kampilladi churna is taken up for the present study because no study was carried out in the management of Madhumeha, drugs required for the preparation of churna are easily available, socio economic and method for preparation of churna is very easy. It does not contain any preservatives, can be easily taken by patient.

Study methodology

Type of study – Randomized Controlled Trial.

Location of study - OPD  department of Kayachikitsa.

Duration of Study - 18 months after approval of synopsis.

Duration of treatment –90 days. Last assessment – on 90 th day

Study setting

Total no of pts-70

Group A – Kampilladi Churna with 35 number of patients. (trial group) BD (before meal) 5GM twice a day with ushnodaka as anupan

Group B –Vallipanchamool Churna with 35 number of patients. ( control group)BD ( before meal ) 5GM twice a day****with ushnodaka as anupan

Follow up after every 15 days [0th, 15th, 30th, 45th,60th ,75th ,90th day] Final assessment of patient on 90 th day.

Patients suffering from lakshanas of Madhumeha in the age group of 30 years to 70 years, as they visit OPD  of Kayachikitsa department will be studied randomly irrespective of sex, religion, educational and economic status. Pathya(Ahara and Vihar regimen) -Proper diabetic diet pathya (ahara and vihara regimen)will be advised to the patients.

Subjective Parameters -1) Mukhamadhurya(sweetness in mouth)     2) Karpadasupti(numbness in palm and foot)    3) Dantadinammaladhikya(infection)     ] 4) Nidradhikya(excess sleep)     5) Pipasavriddhi(polydipsia)

  1. Mutradhikya(polyuria)[      7) Swedadhikya(excess perspiration)      8) Karpadadaha(burning sensation in palm and foot)    9) Alasya(general debility)    10) Kshudhadhikya (increase in appetite)    11) Daurbalata (weakness)

Ojective parameters

1)RBS and PBS Every 15 th days

Day 1 -0th day -1st asssessment

1 st Follow up - will be on 15 thday.

2 nd Follow up – will be on 30 th day.

3 rd Follow up - will be on 45th day.

4 th follow up- will be on 60th day.

5 th follow up- will be on 75th day.

6th last  follow up- will be on 90th day.

2)HbA1C At 0th day and 90th day

Identification of drug - It will be done in Dravyaguna department of study Centre.

Standardization - Standardization will be made from Rasashastra department of Study after preparation of drug before the clinical trials will be conducted.

The drugs will be prepared as stated by Kampilladi Churna as per chakradutta and Vallipanchamool churna as per reference of Sushrutsamhita.

PATHYA ( Ahara and Vihara regimen)  Ahara- [] Patients should follow the following ahara: Moong, Chana, Gehu, Satu, Nachni, Karela, old grains.

Others-Dhani, laja/murmura ,maricha ,saindhava ,hingu ,haridra ,adraka

Vihar-  Upto 45 minutes of aerobic exercise per day will be advised to the patients .

  1. Vyayama -Which includes brisk walking ,jogging, bicycling, swimming

2)Kreeda(games).playing badminton and tennis.

3)Yoga

Vallipanchmoola Churna         Guduchi-1part

Vidari -1part

Sariva -1part

Rajani -1part

Ajashringi-1part

Kampilladi Churna           Kampillaka-1part

Kutaj- 1part -

kapittha-1part

saptaparna-1part

shal-1part

Rohitak -1part

Bibhitak-1part

Conclusion will be drawn on overall assessment, tabulation, statistical analysis and graphic presentation of data

After applying statistical test to data results will be generated

And Results will be published .

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Subject with age between 30 to 70 years of both sexes.
  • Newly diagnosed patients of Type II Diabetes Mellitus fulfilling criteria of diagnosis having 50% and more than 50% of cardinal signs and symptoms of Madhumeha.
  • Subject with post meal blood sugar between 200-250 mg/dI.
  • Subject with HbA1c between 6.5- 8%.
  • Patients with Controlled Hypertension with medications (on drugs), fulfilling above criteria of diagnosis of Type II Diabetes Mellitus (Madhumeha) 7)Subject who is willing ready to participate in the research project.

排除标准

  • Subject with complications of Diabetes Mellitus (Type II).
  • Pregnant and lactating women.
  • Subjects with multiple endocrine disorders, malignancy or other systemic illness affecting blood sugar level.
  • Participate in other clinical trial.

结局指标

主要结局

1.To evaluate the clinical efficacy of Kampilladi churna in the management of

时间窗: Follow up of Fbs and Pbs is at 0th,15th,30th | ,45th,60th ,75th ,90th day | Hba1c at 0th day and 90 th day | Final assessment on 90th day

Madhumeha w.s.r. to Diabetes mellitus type II.

时间窗: Follow up of Fbs and Pbs is at 0th,15th,30th | ,45th,60th ,75th ,90th day | Hba1c at 0th day and 90 th day | Final assessment on 90th day

Blood sugar will be assessed by Objective criteria will be assessed by glucometer i.e

时间窗: Follow up of Fbs and Pbs is at 0th,15th,30th | ,45th,60th ,75th ,90th day | Hba1c at 0th day and 90 th day | Final assessment on 90th day

FBS AND PBS every 15 days and

时间窗: Follow up of Fbs and Pbs is at 0th,15th,30th | ,45th,60th ,75th ,90th day | Hba1c at 0th day and 90 th day | Final assessment on 90th day

HbA1C will be assessed on 0th day and 90th day

时间窗: Follow up of Fbs and Pbs is at 0th,15th,30th | ,45th,60th ,75th ,90th day | Hba1c at 0th day and 90 th day | Final assessment on 90th day

2. To study the etiopathology of Madhumeha w.s.r. to Diabetes mellitus type II.

时间窗: Follow up of Fbs and Pbs is at 0th,15th,30th | ,45th,60th ,75th ,90th day | Hba1c at 0th day and 90 th day | Final assessment on 90th day

次要结局

  • 1.Subjevtive criteria of madhumeha will be assessed by scoring pattern developed by Guddoye and Vyas–(1) Mukhamadhurya(sweetness in mouth))

研究者

发起方
Dr Bhumika Rajai
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Bhumika Rajai

Bhausaheb Mulak Ayurveda Mahavidyalaya and Reseach Hospital,Nandanwan,Nagpur

研究点 (1)

Loading locations...

相似试验